CYM — Cymat Technologies Balance Sheet
0.000.00%
Last trade - 00:00- CA$13.04m
- CA$18.49m
- CA$3.71m
Annual balance sheet for Cymat Technologies, fiscal year end - April 30th, CAD millions except per share, conversion factor applied.
2021 April 30th | 2022 April 30th | 2023 April 30th | 2024 April 30th | 2025 April 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 5.02 | 2.47 | 0.324 | 0.056 | 0.354 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.165 | 0.838 | 0.059 | 0.184 | 0.161 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5.47 | 4.75 | 1.27 | 1.57 | 0.862 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.09 | 1.08 | 2.85 | 2.36 | 1.87 |
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 6.58 | 6.17 | 4.16 | 3.96 | 2.76 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.96 | 2.15 | 2.21 | 4.54 | 5.73 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 3.71 | 3.83 | 4.77 | 6.78 | 7.49 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 2.88 | 2.34 | -0.612 | -2.81 | -4.73 |
| Total Liabilities & Shareholders' Equity | 6.58 | 6.17 | 4.16 | 3.96 | 2.76 |
| Total Common Shares Outstanding |